ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,469.30
0.39%
Dow Jones
39,112.16
-0.76%
US Dollar vs MXN
18.1347
0.05%
Brent Oil
84.095
-0.11%
Bitcoin
61,769.37
-0.05%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Applied Molecular Transport Inc (AMTI)

  7. Applied Molecular Transport Inc (AMTI) Noticias

AMTI

Applied Molecular Transp... (AMTI)

Applied Molecular Transport Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:AMTI
FechaHoraFuenteTítuloSímboloCompañía
09/01/202405:12Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:AMTIApplied Molecular Transport Inc
02/01/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AMTIApplied Molecular Transport Inc
02/01/202408:15Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:AMTIApplied Molecular Transport Inc
02/01/202408:14Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AMTIApplied Molecular Transport Inc
02/01/202408:14Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:AMTIApplied Molecular Transport Inc
28/12/202316:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMTIApplied Molecular Transport Inc
27/12/202315:15Business WireCyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.NASDAQ:AMTIApplied Molecular Transport Inc
27/12/202314:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMTIApplied Molecular Transport Inc
15/12/202315:06Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AMTIApplied Molecular Transport Inc
21/11/202308:16Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:AMTIApplied Molecular Transport Inc
09/11/202315:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AMTIApplied Molecular Transport Inc
09/11/202315:01GlobeNewswire Inc.Applied Molecular Transport Reports Third Quarter 2023 Financial ResultsNASDAQ:AMTIApplied Molecular Transport Inc
27/09/202310:47Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:AMTIApplied Molecular Transport Inc
21/09/202307:05Business WireCyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger AgreementNASDAQ:AMTIApplied Molecular Transport Inc
14/08/202315:01GlobeNewswire Inc.Applied Molecular Transport Reports Second Quarter 2023 Financial ResultsNASDAQ:AMTIApplied Molecular Transport Inc
15/06/202316:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMTIApplied Molecular Transport Inc
15/06/202315:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AMTIApplied Molecular Transport Inc
08/06/202315:05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AMTIApplied Molecular Transport Inc
11/05/202315:05GlobeNewswire Inc.Applied Molecular Transport Reports First Quarter 2023 Financial ResultsNASDAQ:AMTIApplied Molecular Transport Inc
28/04/202315:30Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AMTIApplied Molecular Transport Inc
27/03/202315:01GlobeNewswire Inc.Applied Molecular Transport Announces Corporate Leadership Change and Process to Explore Strategic AlternativesNASDAQ:AMTIApplied Molecular Transport Inc
09/03/202315:20Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AMTIApplied Molecular Transport Inc
09/03/202315:05GlobeNewswire Inc.Applied Molecular Transport Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate UpdateNASDAQ:AMTIApplied Molecular Transport Inc
03/03/202307:00GlobeNewswire Inc.Applied Molecular Transport Presents Additional Data from Oral AMT-101 Phase 2 FILLMORE Trial in Chronic Pouchitis at ECCO ’23 CongressNASDAQ:AMTIApplied Molecular Transport Inc
09/02/202315:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMTIApplied Molecular Transport Inc
22/12/202216:30GlobeNewswire Inc.Applied Molecular Transport Announces Top-line Phase 2 Results from LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative ColitisNASDAQ:AMTIApplied Molecular Transport Inc
10/11/202208:10Dow Jones NewsApplied Molecular Transport Gets New FDA Orphan Drug DesignationNASDAQ:AMTIApplied Molecular Transport Inc
10/11/202207:00GlobeNewswire Inc.Applied Molecular Transport Announces FDA Orphan Drug Designation Granted to AMT-101 for Treatment of PouchitisNASDAQ:AMTIApplied Molecular Transport Inc
09/11/202222:25TipRanksSVB Securities Remains a Buy on Applied Molecular Transport (AMTI)NASDAQ:AMTIApplied Molecular Transport Inc
08/11/202207:00GlobeNewswire Inc.Applied Molecular Transport to Present at Upcoming November Investor ConferencesNASDAQ:AMTIApplied Molecular Transport Inc
 Showing the most relevant articles for your search:NASDAQ:AMTI

Su Consulta Reciente

COIN
BPSGBP
LSE
41UQ
Paragon 25c S
LSE
COMG
Amd Commo Exagr
NASDAQ
TPIC
TPI Composites
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados